🇺🇸 CpG-adjuvanted HBV Vaccine in United States

CpG-adjuvanted HBV Vaccine (CpG-adjuvanted HBV Vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

CpG-adjuvanted HBV Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CpG-adjuvanted HBV Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CpG-adjuvanted HBV Vaccine in United States?

NYU Langone Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.